We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+15.88%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$574M
AUM Growth
+$39M
Cap. Flow
-$18.7M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.53%
Holding
332
New
30
Increased
74
Reduced
75
Closed
30

Sector Composition

Rank Sector Weight
1 Industrials 27.35%
2 Technology 24.24%
3 Healthcare 22.49%
4 Financials 5.86%
5 Consumer Discretionary 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNRC icon
26
Generac Holdings
GNRC
$13.1B
$5.55M 0.97%
34,940
-1,234
-3% -$183K
LINC icon
27
Lincoln Educational Services
LINC
$945M
$5.3M 0.92%
443,739
+1,490
+0.3% +$18.5K
TRNS icon
28
Transcat
TRNS
$915M
$5.25M 0.91%
43,444
+171
+0.4% +$21.2K
CLPT icon
29
ClearPoint Neuro
CLPT
$463M
$5.2M 0.91%
463,853
+1,267
+0.3% +$12.1K
STKL
30
DELISTED
SunOpta
STKL
$5.18M 0.9%
811,188
-38,304
-5% -$224K
PATK icon
31
Patrick Industries
PATK
$2.79B
$5.13M 0.89%
54,065
-21,375
-28% -$1.79M
AGX icon
32
Argan
AGX
$8.02B
$5.03M 0.88%
49,578
-7,213
-13% -$570K
KNSA icon
33
Kiniksa Pharmaceuticals
KNSA
$6.1B
$5.01M 0.87%
200,516
+717
+0.4% +$17.5K
LYTS icon
34
LSI Industries
LYTS
$890M
$4.95M 0.86%
306,397
+1,111
+0.4% +$17K
AMBA icon
35
Ambarella
AMBA
$3.66B
$4.82M 0.84%
85,424
-1,795
-2% -$95.5K
SEM
36
DELISTED
Select Medical
SEM
$4.79M 0.84%
255,105
-10,761
-4% -$206K
EOLS icon
37
Evolus
EOLS
$536M
$4.79M 0.83%
295,553
+1,111
+0.4% +$15.5K
BP icon
38
BP
BP
$111B
$4.73M 0.83%
150,815
-6,209
-4% -$210K
GMED icon
39
Globus Medical
GMED
$11.5B
$4.72M 0.82%
65,986
-3,910
-6% -$276K
GS icon
40
Goldman Sachs
GS
$302B
$4.7M 0.82%
9,484
-754
-7% -$369K
EVER icon
41
EverQuote
EVER
$867M
$4.57M 0.8%
216,694
+30,619
+16% +$700K
UVE icon
42
Universal Insurance Holdings
UVE
$1.18B
$4.47M 0.78%
201,639
+79,138
+65% +$1.6M
PFE icon
43
Pfizer
PFE
$150B
$4.37M 0.76%
+150,992
New +$4.4M
ITCI
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.27M 0.74%
58,385
+26,937
+86% +$2.02M
OSPN icon
45
OneSpan
OSPN
$609M
$4.27M 0.74%
256,029
+681
+0.3% +$10.1K
PAY icon
46
Paymentus
PAY
$5.08B
$4.21M 0.73%
210,184
+489
+0.2% +$10.2K
NOVT icon
47
Novanta
NOVT
$6.32B
$4.18M 0.73%
23,379
+80
+0.3% +$13.9K
ERII icon
48
Energy Recovery
ERII
$397M
$4.13M 0.72%
237,426
-7,262
-3% -$115K
NVRI icon
49
Enviri
NVRI
$583M
$4.02M 0.7%
388,870
+1,056
+0.3% +$11.1K
SG icon
50
Sweetgreen
SG
$693M
$3.99M 0.7%
112,647
+314
+0.3% +$9.54K

Similar funds

Essex Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, Essex Investment Management held 332 positions worth $574M, up 7.3% from $535M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Essex Investment Management withdrew a net $18.7M in Q3 2024, closing 30 positions and reducing 75 holdings. Its most notable exit was Dynavax Technologies, an estimated $4.71M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Essex Investment Management opened a new position in Pfizer worth $4.37M.

  • Essex Investment Management's largest Q3 2024 buy was Pfizer: 150,992 shares worth $4.37M.
  • Essex Investment Management added most to Crexendo in Q3 2024, an estimated $3.36M increase.
  • Essex Investment Management's biggest Q3 2024 reduction was Apple, cutting an estimated $2.87M.
  • Essex Investment Management fully exited Dynavax Technologies in Q3 2024, selling an estimated $4.71M.
  • Essex Investment Management's ten largest holdings make up 17% of its $574M portfolio in Q3 2024.
  • Essex Investment Management opened 30 new positions and closed 30 in Q3 2024.
  • Essex Investment Management's portfolio value rose 7.3% quarter-over-quarter to $574M.

Based on Essex Investment Management's 13F filing for Q3 2024, filed 10 Oct 2024.